10 Wall Street Analysts Think Argenx Stock Is Headed to At Least $1,200 -- Is the Stock a Buy Now?
This biotech stock could soar 30% or more over the next 12 months if some analysts are right.
We haven't written up this one. Motley Fool has the full story — the link below goes straight to it.